Peri-procedural Myocardial Injury. Injury of heart, unspecified with or without hemopericardium
Conditions
Interventions
Intervention 1: Intervention group: Receive the standard pretreatment protocol in patients undergoing Percutaneous Coronary Intervention (aspirin, and Clopidogrel) along with 1000 mg per day Oral admi
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with ischemic heart disease and candidates for PCI or acute coronary syndrome who referred for coronary angiography with a possible clinical indication for PCI Patients with acute coronary syndrome and candidates for PCI Patients have undergone elective and non-emergency PCI Consent to participate in the present study
Exclusion criteria
Exclusion criteria: using the oral steroid drugs or NSAIDs except aspirin Active malignancy or infection History of Myelodysplasia Severe Hepatic dysfunction (AST or ALT more than 3 times UMN) Pregnancy Renal dysfunction (serum creatinine more than 2.5 mg/dL or undergoing dialysis) History of revascularization (PCI or CABG)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of hs-Troponin-I. Timepoint: before PCI and 24 hours after PCI. Method of measurement: Immunoassay.;Serum levels of hs-CRP. Timepoint: before PCI and 24 hours after PCI. Method of measurement: Immunoassay. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stent thrombosis. Timepoint: 30 days after PCI. Method of measurement: Observation, ECG, Echocardiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKaveh OraiiYazdani
Zahedan University of Medical Sciences
Outcome results
None listed